Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
Rhea-AI Summary
Bausch Health (NYSE:BHC) and Ortho Dermatologics announced the 2026 ASPIRE HIGHER Scholarship Program, awarding six students impacted by dermatologic conditions with scholarships of up to $10,000 each. Applications are open through June 10, 2026, and recipients will be notified in July 2026.
Eligible applicants include current or prospective students for the 2026–2027 academic year at two- or four-year colleges, universities, or advanced vocational/technical schools; three undergraduate and three graduate awards will be offered. Applicants must submit an essay and two letters of reference. More details at the program website.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
In the Mar 26 session, BHC gained 0.79%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Aesthetics product launch | Positive | -2.5% | Health Canada-approved launch of Clear + Brilliant Touch laser in Canada. |
| Feb 19 | Product anniversary | Positive | -4.2% | 25th anniversary of ARESTIN with expanded presence in Canada and Puerto Rico. |
| Feb 18 | Earnings and guidance | Positive | -4.2% | Q4 and full-year 2025 results with revenue growth and 2026 guidance. |
| Feb 17 | Conference participation | Neutral | +0.0% | Planned attendance at J.P. Morgan Global Leveraged Finance Conference. |
| Feb 11 | Scholarship program | Positive | -1.3% | Launch of Salix GI Health Scholars Program offering 10 scholarships up to $10,000. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news, including product launches, anniversaries, earnings, and prior scholarship programs, has often been followed by flat to negative 24-hour price reactions, suggesting limited short-term upside response to generally positive updates.
Over recent months, Bausch Health has highlighted aesthetics and dental franchises, reporting Health Canada approval-backed rollout of Clear + Brilliant Touch in Canada and celebrating 25 years of ARESTIN with geographic expansion. The company also posted Q4 2025 revenues of $2.80B and full-year $10.27B, alongside 2026 guidance. Investor events and disease-focused scholarship initiatives, such as the 2026 Gastrointestinal Health Scholars Program offering 10 scholarships up to $10,000, show an ongoing push in patient engagement and franchise visibility, into which this new dermatology scholarship program fits.
Key Terms
dermatologic conditions medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with applications open through June 2026
"It is an honor to continue the ASPIRE HIGHER Scholarship Program and support students who have demonstrated resilience while managing dermatologic conditions," said Tom Stern, Vice President and General Manager, Ortho Dermatologics, Bausch Health. "These students inspire us with their determination, and we are proud to recognize their achievements and the healthcare providers who play an important role in their care."
Eligible students may apply by completing an online application, submitting an essay describing the impact of living with a diagnosed dermatologic condition and the role a healthcare provider has played in helping manage their condition, and providing two letters of reference.
Scholarships are available to students who are current or prospective attendees of a two- or four-year college or university, or an advanced vocational or technical school, for the 2026–2027 academic year and are available in the following categories:
- Three Undergraduate Scholar Awards—for students pursuing undergraduate or vocational/technical degrees
- Three Graduate Scholar Awards—for students pursuing graduate-level degrees
The application period for the 2026 ASPIRE HIGHER Scholarship Program will close on June 10, 2026, and scholarship recipients will be notified in July 2026.
To learn more about the scholarship program, including eligibility criteria, terms and conditions, and stories from previous recipients, visit www.aspirehigherscholarships.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Our dermatology business, Ortho Dermatologics is one of the largest prescription and aesthetic dermatology businesses dedicated to helping patients in the treatment of a range of conditions, including psoriasis, onychomycosis, actinic keratosis, acne, atopic dermatitis and other dermatoses. More information can be found at https://www.ortho-dermatologics.com and connect with us on LinkedIn. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
© 2026 Ortho Dermatologics or its affiliates | |
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
877-281-6642 (toll-free) | (908) 569-3692 |
BHC-ORGANIZATION | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-ortho-dermatologics-2026-aspire-higher-scholarship-program-302725288.html
SOURCE Bausch Health Companies Inc.